Skip to main navigation Skip to search Skip to main content

A 12-Month, Dose-Level Blinded Study Investigating the Safety and Efficacy of CVT-301 (Levodopa Inhalation Powder) in Parkinson's Disease Patients With Motor Response Fluctuations (OFF Phenomena)

  • Mihaila, Dragos (PI)

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date04/8/15 → 10/7/19

Funding

  • Acorda Therapeutics: $9,041.67